Accumulation of indoxyl-beta-D-glucuronide in uremic serum: suppression of its production by oral sorbent and efficient removal by hemodialysis.
T Niwa, T Miyazaki, S Tsukushi, K Maeda, Y Tsubakihara, A Owada, T Shiigai
文献索引:Nephron 74(1) , 72-8, (1996)
全文:HTML全文
摘要
We identified and quantified indoxyl-beta-D-glucuronide in uremic serum and urine to determine the metabolism of indoles including indoxyl sulfate in uremic patients. Serum levels of indoxyl-beta-D-glucuronide were markedly increased in undialyzed uremic patients, in patients on hemodialysis, and in patients on continuous ambulatory peritoneal dialysis. Urinary excretion of indoxyl-beta-D-glucuronide was also increased in undialyzed uremic patients. Urinary indoxyl-beta-D-glucuronide was significantly correlated with serum indoxyl sulfate, indicating that a high serum level of indoxyl sulfate leads to the enhanced synthesis of indoxyl-beta-D-glucuronide. Oral sorbent (AST-120) administration markedly decreased the serum and urine levels of indoxyl-beta-D-glucuronide as well as indoxyl sulfate in the undialyzed uremic patients. Serum indoxyl-beta-D-glucuronide could be efficiently removed by hemodialysis despite its high protein-binding ratio of about 50%. In conclusion, the serum level of indoxyl-beta-D-glucuronide increases in uremic patients due to renal insufficiency and its increased production. The production of indoxyl-beta-D-glucuronide can be suppressed by oral sorbent treatment, and serum indoxyl-beta-D-glucuronide can be efficiently removed by hemodialysis.
相关化合物
相关文献:
1989-04-01
[J. Clin. Microbiol. 27 , 778-779, (1989)]
1996-09-01
[Rinsho Byori. 44(9) , 895-8, (1996)]
2001-05-01
[J. Agric. Food Chem. 49(5) , 2137-41, (2001)]
1996-01-01
[Appl. Environ. Microbiol. 62(1) , 203-8, (1996)]
1994-08-01
[Clin. Chem. 40(8) , 1580-6, (1994)]